STRENZA PLUS
openFDA label record#
This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON
- Brand name
- STRENZA PLUS
- Generic name
- MOXIFLOXACIN 0.5%, BROMFENAC 0.09%, PREDNISOLONE ACETATE 1%
- Manufacturer
- Brisk Pharmaceuticals
- Product type
- HUMAN PRESCRIPTION DRUG
- SPL set ID
- 2df9064c-0527-4c21-e063-6294a90a56d8
- SPL ID
- 2df9064c-0528-4c21-e063-6294a90a56d8
- Version
- 1
- Effective date
- 2025-02-12
- Source export date
- 2026-11-06
- Source partition
- 7
- Source file
- https://download.open.fda.gov/drug/label/drug-label-0007-of-0014.json.zip
- Source object key
- raw/openfda/drug-label/2026-11-06/90742968499056f8845d54427ea2950526b02c3f289aedd40679ed8e120a0e89/drug-label-0007-of-0014.json.zip
- Source manifest SHA-256
- 8dff71fbef1291eb7711013e9a3a06194930757924a8946ae3034107a98d9463
- Import run
- 20261106T075659Z
- Imported at
- 2026-11-06 08:41:45
| Harmonized routes |
|---|
| OPHTHALMIC |
Harmonized identifier links#
Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
| Type | Scope | Identifier | Source field |
|---|---|---|---|
| brand name | STRENZA PLUS | openfda.brand_name | |
| generic name | MOXIFLOXACIN 0.5%, BROMFENAC 0.09%, PREDNISOLONE ACETATE 1% | openfda.generic_name | |
| manufacturer name | Brisk Pharmaceuticals | openfda.manufacturer_name | |
| ndc | package | 72266-142-01 | openfda.package_ndc |
| ndc | package | 73614-732-03 | openfda.package_ndc |
| ndc | product | 73614-732 | openfda.product_ndc |
| ndc11 | package | 72266014201 | derived:openfda.package_ndc |
| ndc11 | package | 73614073203 | derived:openfda.package_ndc |
| rxcui | 578018 | openfda.rxcui | |
| rxcui | 1376336 | openfda.rxcui | |
| rxcui | 403818 | openfda.rxcui | |
| spl id | 2df9064c-0528-4c21-e063-6294a90a56d8 | id | |
| spl set id | 2df9064c-0527-4c21-e063-6294a90a56d8 | set_id |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.